Gilbert Fuller Sells 1,058 Shares of USANA Health Sciences (NYSE:USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNAGet Free Report) Director Gilbert Fuller sold 1,058 shares of the stock in a transaction dated Friday, March 20th. The stock was sold at an average price of $17.00, for a total transaction of $17,986.00. The sale was disclosed in a filing with the SEC, which is available through this link.

USANA Health Sciences Trading Down 1.5%

Shares of NYSE USNA opened at $16.88 on Friday. USANA Health Sciences, Inc. has a 1-year low of $16.72 and a 1-year high of $38.32. The company has a 50-day moving average of $20.29 and a two-hundred day moving average of $21.81. The company has a market cap of $311.66 million, a PE ratio of 30.70, a P/E/G ratio of 0.70 and a beta of 0.64.

USANA Health Sciences (NYSE:USNAGet Free Report) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.41 by $0.19. The business had revenue of $226.20 million for the quarter, compared to analysts’ expectations of $225.96 million. USANA Health Sciences had a net margin of 1.16% and a return on equity of 6.75%. As a group, equities research analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Hedge Funds Weigh In On USANA Health Sciences

A number of hedge funds and other institutional investors have recently bought and sold shares of USNA. Exchange Traded Concepts LLC raised its position in shares of USANA Health Sciences by 497.0% during the 3rd quarter. Exchange Traded Concepts LLC now owns 47,204 shares of the company’s stock valued at $1,300,000 after acquiring an additional 39,297 shares during the last quarter. Walleye Capital LLC lifted its stake in shares of USANA Health Sciences by 257.3% in the 2nd quarter. Walleye Capital LLC now owns 45,829 shares of the company’s stock valued at $1,399,000 after purchasing an additional 33,001 shares during the period. Allianz Asset Management GmbH boosted its position in shares of USANA Health Sciences by 126.0% in the 3rd quarter. Allianz Asset Management GmbH now owns 47,203 shares of the company’s stock worth $1,300,000 after purchasing an additional 26,314 shares during the last quarter. Franklin Resources Inc. boosted its position in shares of USANA Health Sciences by 16.2% in the 2nd quarter. Franklin Resources Inc. now owns 12,930 shares of the company’s stock worth $395,000 after purchasing an additional 1,807 shares during the last quarter. Finally, Intech Investment Management LLC acquired a new stake in shares of USANA Health Sciences during the second quarter worth $208,000. 54.25% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on USNA shares. Weiss Ratings reissued a “sell (d)” rating on shares of USANA Health Sciences in a research note on Monday, December 29th. Wall Street Zen raised USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Finally, Zacks Research upgraded USANA Health Sciences from a “strong sell” rating to a “hold” rating in a report on Monday, February 16th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Reduce”.

Check Out Our Latest Analysis on USANA Health Sciences

USANA Health Sciences Company Profile

(Get Free Report)

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.

Featured Stories

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.